Investigating colorectal cancer risk factors and blood biomarkers based on tumor types
Official title: Colorectal cancer risk factors, risk prediction and blood-based biomarker by tumor consensus molecular subtype
Funded at University of Kansas Medical Center · NIH-10591999 · Data updated 2026-11-12
This study is looking at different types of colorectal cancer to find out how they behave and what makes some people more at risk, so that we can create better ways to catch it early and help those at higher risk with more personalized screening options.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kansas Medical Center NIH-funded |
| Lab location | 1 site (Kansas City, United States) |
| Project start | September 20, 2019 |
| Project end | August 31, 2025 |
| Funding year | 2021 |
| Award (this year) | $222,027 |
| NIH project number | 7U01CA222163-04 |
| Project ID | NIH-10591999 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals at high risk for colorectal cancer, particularly those with a family history or genetic predispositions.
✕Less likely to help
Patients with non-colorectal cancers or those who do not have risk factors for colorectal cancer may not benefit from this research.
What this research studies
This research focuses on understanding the different types of colorectal cancer (CRC) and their associated risk factors. It aims to improve early detection by examining blood-based biomarkers linked to specific tumor subtypes, which may have varying aggressiveness and biological characteristics. By identifying these subtypes, the study seeks to enhance risk prediction and develop tailored screening strategies for individuals at higher risk. Patients may benefit from more personalized prevention and early detection methods based on their tumor profile.
Why it matters
Potential benefit: If successful, this research could lead to improved early detection and prevention strategies for colorectal cancer, potentially reducing morbidity and mortality.
How similar studies have gone: Other research has shown promise in using tumor subtypes to tailor cancer screening and treatment, indicating that this approach may lead to significant advancements.
Where this research is happening
-
University of Kansas Medical Center
Kansas City, United States Active
Researchers
- Principal investigator: Davis, Jennifer Sarah — University of Kansas Medical Center
- Study coordinator: Davis, Jennifer Sarah
Related research
Other NIH-funded projects on the same topics.
-
Investigating early life factors and screening patterns for young colorectal cancer patients
This study is looking at what early life factors might lead to colorectal cancer in people under 50, and it also wants to see how screening for this cancer has changed over the years, especially with new guidelines and the effects of the COVID-19 pandemic, to help find better ways to catch it early.
-
Investigating the link between antibiotic use, high birth weight, and early-onset colorectal cancer
This study is looking at how certain factors, like taking antibiotics and being born with a high birth weight, might increase the risk of colorectal cancer in young adults under 50, and it’s inviting people to share their health and lifestyle information to help us understand this better.
-
Improving colorectal cancer screening and follow-up care.
This study is working to help more people get screened for colorectal cancer and receive the follow-up care they need, especially those who haven't been screened much before, so that everyone can have better access to important health checks and improve their overall health.
-
IOP and CSF Pressure in Glaucoma Risk
This grant studies how eye pressure and cerebrospinal fluid pressure together influence glaucoma risk and vision loss.
-
ALS risk factors in a long-term ALS study
A long-term ALS study is looking at which factors may influence disease risk and progression in people living with ALS.
-
Understanding how work exposures and genes influence ALS risk
A study is building a long-term group of people at higher risk for ALS to see how their jobs, exposures at work, and genes together affect if and when the disease might develop.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.